| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gorman Kevin Charles is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $82.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 106,322 | $126.41 | $13,440,280.97 | -17.1% | +22.4% | - | |
| Jun 16, 2025 | XNCR Xencor Inc | Director | Sell | 3,173 | $9.22 | $29,255.06 | -14.4% | -6.2% | +36.2% | |
| May 27, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sell | 9,613 | $120.38 | $1,157,211.02 | -1.8% | +9.3% | +27.1% | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 5,844 | $116.69 | $681,914.46 | -0.6% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 2,274 | $118.37 | $269,167.24 | -0.4% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 2,707 | $152.92 | $413,966.89 | -0.5% | -29.8% | -10.4% | |
| Jan 27, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 146,105 | $149.46 | $21,836,502.65 | -22.1% | -28.2% | -9.6% | |
| Sep 27, 2024 | XNCR Xencor Inc | Director | Sell | 2,654 | $20.68 | $54,884.72 | -24.0% | +22.5% | -42.9% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 2,832 | $133.02 | $376,700.46 | -0.5% | +1.7% | -12.4% | |
| Feb 13, 2024 | XNCR Xencor Inc | Director | Buy | 53 | $19.12 | $1,013.36 | +1.1% | +11.6% | -15.2% |